FRANKLIN C WONG to Doxorubicin
This is a "connection" page, showing publications FRANKLIN C WONG has written about Doxorubicin.
Connection Strength
0.059
-
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy. J Clin Oncol. 2005 Nov 01; 23(31):7904-10.
Score: 0.040
-
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer. Cancer. 2015 Jan 01; 121(1):69-76.
Score: 0.019